Pharmaron Beijing Co., Ltd. (SHE:300759)

Pharmaron Beijing Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,263	1,690	5,919	1,497	3,544	2,942
Short-Term Investments	-	257.27	179.36	613.24	1,080	-
Trading Asset Securities	1,426	1,120	621.98	745.36	1,555	910.01
Cash & Short-Term Investments	2,689	3,068	6,720	2,856	6,178	3,852
Cash Growth	-49.78%	-54.35%	135.30%	-53.77%	60.37%	-17.03%
Accounts Receivable	2,791	2,871	2,636	2,214	1,424	1,210
Other Receivables	109.53	126.89	80.98	71.16	92.43	33.38
Receivables	2,900	2,998	2,717	2,286	1,516	1,249
Inventory	1,167	1,117	1,013	1,041	680.04	281.62
Other Current Assets	628.92	425.67	423.68	352.82	269.05	157.76
Total Current Assets	7,384	7,608	10,874	6,536	8,644	5,540
Property, Plant & Equipment	10,964	10,798	10,062	8,464	5,811	3,799
Long-Term Investments	1,073	883.04	1,005	1,008	762.67	401.7
Goodwill	2,947	2,761	2,781	2,688	2,096	1,166
Other Intangible Assets	837.51	791	789.06	802.53	692.94	566.08
Long-Term Deferred Tax Assets	227.07	192.68	153.22	58.79	15.6	8.44
Long-Term Deferred Charges	657.6	678.5	520.47	496.38	171.6	234.27
Other Long-Term Assets	240.94	191.98	267.09	438.91	195.99	193.05
Total Assets	24,333	23,927	26,477	20,493	18,389	11,909
Accounts Payable	484.26	477.09	412.22	406.35	315.53	191.5
Accrued Expenses	794.59	853.93	805.65	784.92	626.21	472.44
Short-Term Debt	799.19	764.97	577.07	662.77	421.76	377.27
Current Portion of Long-Term Debt	426.7	282.34	150.34	74.94	60.54	8.88
Current Portion of Leases	-	149.51	185.32	164.03	95.29	83.92
Current Income Taxes Payable	206.78	160.08	184.55	145.87	81.34	27.62
Current Unearned Revenue	859.18	834.86	740.87	832.14	679.62	473.29
Other Current Liabilities	653.2	701.23	598.47	841.4	701.7	346.87
Total Current Liabilities	4,224	4,224	3,654	3,912	2,982	1,982
Long-Term Debt	4,357	4,377	8,200	4,454	4,423	394.81
Long-Term Leases	375.59	401.31	585.2	760.51	284.34	186.61
Long-Term Unearned Revenue	417.04	409.98	391.71	152.38	149.44	158.13
Long-Term Deferred Tax Liabilities	312.9	291.87	290.04	261.01	173.3	106.91
Other Long-Term Liabilities	-	-	117.58	112.09	81.56	146.81
Total Liabilities	9,687	9,705	13,239	9,653	8,094	2,975
Common Stock	1,778	1,778	1,787	1,191	794.18	794.39
Additional Paid-In Capital	5,026	5,008	5,222	5,254	6,008	6,028
Retained Earnings	7,563	7,257	5,818	4,574	3,554	2,131
Treasury Stock	-422.98	-416.27	-463.45	-668.04	-301.83	-45.47
Comprehensive Income & Other	98.55	-7.76	193.72	197.26	74.15	-38.22
Total Common Equity	14,042	13,619	12,557	10,549	10,129	8,870
Minority Interest	603.95	603.54	681.25	291.25	166.07	63.42
Shareholders' Equity	14,646	14,223	13,238	10,840	10,295	8,934
Total Liabilities & Equity	24,333	23,927	26,477	20,493	18,389	11,909
Total Debt	5,959	5,975	9,698	6,117	5,285	1,051
Net Cash (Debt)	-3,270	-2,908	-2,977	-3,260	893.04	2,801
Net Cash Growth	-	-	-	-	-68.12%	-22.27%
Net Cash Per Share	-1.85	-1.64	-1.68	-1.84	0.49	1.57
Filing Date Shares Outstanding	1,760	1,766	1,787	1,787	1,787	1,787
Total Common Shares Outstanding	1,760	1,766	1,787	1,787	1,787	1,787
Working Capital	3,161	3,384	7,220	2,624	5,662	3,559
Book Value Per Share	7.98	7.71	7.03	5.90	5.67	4.96
Tangible Book Value	10,257	10,068	8,987	7,058	7,340	7,138
Tangible Book Value Per Share	5.83	5.70	5.03	3.95	4.11	3.99
Buildings	-	4,921	3,971	3,347	2,473	1,673
Machinery	-	6,274	5,149	4,265	2,919	2,194
Construction In Progress	-	2,254	2,633	1,671	1,374	820.58

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.